Prostate Cancer

Disease State Hub

Polls

Research Summaries

Conference Coverage

Conference Coverage

Cancer Survival Differences Persist Across Treatment Modalities for Early-Stage Tumors Among People With HIV

04/08/2026

Ashton L. Stahl

A large national database study presented at CROI 2026 in Denver, CO, reports that 5-year survival remains lower for people with HIV compared with people without HIV across most treatment modalities for...

04/08/2026

Research Summary

Research Summary

NeuroSAFE Technique Enhances Erectile Function and Early Continence Recovery After Robot-Assisted Prostatectomy, Randomized Trial Shows

07/30/2025

Kate Young

A multicenter randomized trial has demonstrated that the NeuroSAFE technique significantly improves erectile function and accelerates early urinary continence recovery following robot-assisted radical...

07/30/2025

RESEARCH SUMMARY

RESEARCH SUMMARY

Multinational Study: AI Boosts Prostate Cancer Detection Accuracy in MRI Analysis

07/03/2025

Anthony Calabro, MA

In a multicenter diagnostic study, artificial intelligence assistance significantly improved radiologists’ ability to detect clinically significant prostate cancer on MRI—enhancing sensitivity, specificity,...

07/03/2025

FDA Alert

man on examining room with doctor holding pill bottle

FDA Alert

FDA Approves Darolutamide for Metastatic Castration-Sensitive Prostate Cancer

06/04/2025

Kate Young

The FDA announced the approval of darolutamide for treating metastatic castration-sensitive prostate cancer. This review was conducted under Project Orbis, which allows for concurrent submission and review...

06/04/2025

Research Summary

Research Summary

Darolutamide Monotherapy Lowers PSA in Patients With Hormone-Sensitive Prostate Cancer

02/19/2025

Kate Young

Darolutamide monotherapy reduced prostate-specific antigen response in patients with hormone-sensitive prostate cancer while maintaining testosterone levels in a recent 24-week randomized study.

02/19/2025

April 2026

Current Issue

April 2026